Qi Zhang

Dr. Qi Zhang

Department of Chemistry, Fudan University, Shanghai 200438, China
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2020 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
MMManuel Montalban-Lopez
Manuel Montalban-Lopez
TSThomas A. Scott
Thomas A. Scott
SRSangeetha Ramesh
Sangeetha Ramesh
IRImran R. Rahman
Imran R. Rahman
AHAuke J. van Heel
Auke J. van Heel
WDWilfred A. van der Donk
Wilfred A. van der Donk
This review provides a comprehensive update of the advances in discovery, biosynthesis, and engineering of ribosomally-synthesized and post-translationally modified peptides (RiPPs).

15 March 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
WDWei Ding
Wei Ding
WLWan-Qiu Liu
Wan-Qiu Liu
YJYouli Jia
Youli Jia
YLYongzhen Li
Yongzhen Li
WDWilfred A. van der Donk
Wilfred A. van der Donk
Qi ZhangQi Zhang
Qi Zhang
Production of ribosomally synthesized and posttranslationally modified peptides (RiPPs) has rarely been reported in fungi, even though organisms of this kingdom have a long history as a prolific source of natural products. Here we report an investigation of the phomopsins, antimitotic mycotoxins. We show that phomopsin is a fungal RiPP and demonstrate the widespread presence of a pathway for the biosynthesis of a family of fungal cyclic RiPPs, which we term dikaritins. We characterize PhomM as an S-adenosylmethionine–dependent α-N-methyltransferase that converts phomopsin A to an N,N-dimethylated congener (phomopsin E), and show that the methyltransferases involved in dikaritin biosynthesis have evolved differently and likely have broad substrate specificities. Genome mining studies identified eight previously unknown dikaritins in different strains, highlighting the untapped capacity of RiPP biosynthesis in fungi and setting the stage for investigating the biological activities and unknown biosynthetic transformations of this family of fungal natural products.

3 December 2021 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
SMSuze Ma
Suze Ma
DMDhanaraju Mandalapu
Dhanaraju Mandalapu
SWShu Wang
Shu Wang
Qi ZhangQi Zhang
Qi Zhang
Covering: 2012 to 2021 Cyclopropane attracts wide interests in the fields of synthetic and pharmaceutical chemistry, and chemical biology because of its unique structural and chemical properties. This structural motif is widespread in natural products, and is usually essential for biological activities. Nature has evolved diverse strategies to access this structural motif, and increasing knowledge of the enzymes forming cyclopropane (i.e., cyclopropanases) has been revealed over the last two decades. Here, the scientific literature from the last two decades relating to cyclopropane biosynthesis is summarized, and the enzymatic cyclopropanations, according to reaction mechanism, which can be grouped into two major pathways according to whether the reaction involves an exogenous C1 unit from S-adenosylmethionine (SAM) or not, is discussed. The reactions can further be classified based on the key intermediates required prior to cyclopropane formation, which can be carbocations, carbanions, or carbon radicals. Besides the general biosynthetic pathways of the cyclopropane-containing natural products, particular emphasis is placed on the mechanism and engineering of the enzymes required for forming this unique structure motif.

29 April 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
SGSijia Guo
Sijia Guo
SWShu Wang
Shu Wang
SMSuze Ma
Suze Ma
Zixin DengZixin Deng
Zixin Deng
WDWei Ding
Wei Ding
Qi ZhangQi Zhang
Qi Zhang
Darobactin is a ribosomally synthesized and post-translationally modified peptide (RiPP), which possesses potent activity against various Gram-negative bacteria. Darobactin features a highly unique bicyclic scaffold, consisting of an ether crosslink between two Trp residues and a C–C crosslink between a Lys and a Trp. Here we report in vivo and in vitro activity of darobactin synthase DarE. We show DarE is a radical S-adenosylmethionine (rSAM) enzyme and is solely responsible for forming the bicyclic scaffold of darobactin. DarE mainly produced the ether-crosslinked product in vitro, and when the assay was performed in H218O, apparent 18O incorporation was observed into the ether-crosslinked product. These observations suggested an rSAM-dependent process in darobactin biosynthesis, involving a highly unusual oxygen insertion step from a water molecule and subsequent O–H and C–H activations. Genome mining analysis demonstrates the diversity of darobactin-like biosynthetic gene clusters, a subclade of which likely encode monocyclic products with only an ether linkage. We propose the name daropeptide for this growing family of ether-containing RiPPs produced by DarE enzymes.

21 November 2023 in RSC Chemical Biology
Verified
Journal Article
Open access
PDF file
HLHe Li
He Li
WDWei Ding
Wei Ding
Qi ZhangQi Zhang
Qi Zhang
The major approaches ( i.e. bioactivity-guided screening, genome mining, and biosynthetic engineering) employed in the exploration of RiPP (ribosomally synthesized and post-translationally modified peptides) natural products are discussed in this review.

25 July 2020 in Biotechnology Journal
Verified
Journal Article
Closed access
PDF file
YCYunliang Chen
Yunliang Chen
YYYunpeng Yang
Yunpeng Yang
XJXinjian Ji
Xinjian Ji
RZRan Zhao
Ran Zhao
GLGuoquan Li
Guoquan Li
Qi ZhangQi Zhang
Qi Zhang